Thaddeus J Haight1, William J Jagust. 1. Helen Wills Neuroscience Institute, University of California, Berkeley, CA 94720-3190, USA. tad@berkeley.edu
Abstract
PURPOSE: To assess relationships between biomarkers for Alzheimer's disease (AD) and their potential contributions to AD. METHODS: Biomarkers and cognitive evaluations were assessed longitudinally in 179 patients with mild cognitive impairment, from the Alzheimer's Disease Neuroimaging Initiative from 2003 to 2006, and were used to examine, at any given time, the joint contributions of hippocampal volume, whole brain volume, and brain glucose metabolism on clinical AD progression, using the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog). Marginal structural models were applied, and an inverse-probability of treatment weight estimation was used to account for time-dependent confounding between study variables. RESULTS: At any given time, population-level differences (e.g., 1-standard deviation [SD] increase) in brain glucose metabolism (-1.036; 95% confidence interval [95% CI], -1.608, -0.464) and hippocampal volume (-1.537; 95% CI, -2.399, -0.674) independently reduced mean (ADAS-Cog), whereas a 1-SD increase in whole brain volume did not (0.372; 95% CI, -0.283, 1.027). The effects of brain glucose metabolism differed in subgroups defined by baseline covariates (e.g., age), but no subgroup effects were observed for hippocampal volume and brain volume. CONCLUSIONS: Brain glucose metabolism and hippocampal volume represent relevant biological markers in subjects at risk for AD.
PURPOSE: To assess relationships between biomarkers for Alzheimer's disease (AD) and their potential contributions to AD. METHODS: Biomarkers and cognitive evaluations were assessed longitudinally in 179 patients with mild cognitive impairment, from the Alzheimer's Disease Neuroimaging Initiative from 2003 to 2006, and were used to examine, at any given time, the joint contributions of hippocampal volume, whole brain volume, and brain glucose metabolism on clinical AD progression, using the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog). Marginal structural models were applied, and an inverse-probability of treatment weight estimation was used to account for time-dependent confounding between study variables. RESULTS: At any given time, population-level differences (e.g., 1-standard deviation [SD] increase) in brain glucose metabolism (-1.036; 95% confidence interval [95% CI], -1.608, -0.464) and hippocampal volume (-1.537; 95% CI, -2.399, -0.674) independently reduced mean (ADAS-Cog), whereas a 1-SD increase in whole brain volume did not (0.372; 95% CI, -0.283, 1.027). The effects of brain glucose metabolism differed in subgroups defined by baseline covariates (e.g., age), but no subgroup effects were observed for hippocampal volume and brain volume. CONCLUSIONS:Brain glucose metabolism and hippocampal volume represent relevant biological markers in subjects at risk for AD.
Authors: Clifford R Jack; Matt A Bernstein; Bret J Borowski; Jeffrey L Gunter; Nick C Fox; Paul M Thompson; Norbert Schuff; Gunnar Krueger; Ronald J Killiany; Charles S Decarli; Anders M Dale; Owen W Carmichael; Duygu Tosun; Michael W Weiner Journal: Alzheimers Dement Date: 2010-05 Impact factor: 21.566
Authors: R C Mohs; D Knopman; R C Petersen; S H Ferris; C Ernesto; M Grundman; M Sano; L Bieliauskas; D Geldmacher; C Clark; L J Thal Journal: Alzheimer Dis Assoc Disord Date: 1997 Impact factor: 2.703
Authors: S M Landau; D Harvey; C M Madison; E M Reiman; N L Foster; P S Aisen; R C Petersen; L M Shaw; J Q Trojanowski; C R Jack; M W Weiner; W J Jagust Journal: Neurology Date: 2010-06-30 Impact factor: 9.910
Authors: Francesco Panza; Alessia D'Introno; Anna Maria Colacicco; Cristiano Capurso; Angelo Del Parigi; Richard J Caselli; Alberto Pilotto; Giovanni Argentieri; Pier Luigi Scapicchio; Emanuele Scafato; Antonio Capurso; Vincenzo Solfrizzi Journal: Am J Geriatr Psychiatry Date: 2005-08 Impact factor: 4.105
Authors: L H Kuller; L Shemanski; T Manolio; M Haan; L Fried; N Bryan; G L Burke; R Tracy; R Bhadelia Journal: Stroke Date: 1998-02 Impact factor: 7.914
Authors: Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler Journal: N Engl J Med Date: 2003-03-27 Impact factor: 91.245
Authors: Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski Journal: Lancet Neurol Date: 2010-01 Impact factor: 44.182
Authors: Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Jesse Cedarbaum; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Johan Luthman; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie Shaw; Li Shen; Adam Schwarz; Arthur W Toga; John Q Trojanowski Journal: Alzheimers Dement Date: 2015-06 Impact factor: 21.566
Authors: Genevera I Allen; Nicola Amoroso; Catalina Anghel; Venkat Balagurusamy; Christopher J Bare; Derek Beaton; Roberto Bellotti; David A Bennett; Kevin L Boehme; Paul C Boutros; Laura Caberlotto; Cristian Caloian; Frederick Campbell; Elias Chaibub Neto; Yu-Chuan Chang; Beibei Chen; Chien-Yu Chen; Ting-Ying Chien; Tim Clark; Sudeshna Das; Christos Davatzikos; Jieyao Deng; Donna Dillenberger; Richard J B Dobson; Qilin Dong; Jimit Doshi; Denise Duma; Rosangela Errico; Guray Erus; Evan Everett; David W Fardo; Stephen H Friend; Holger Fröhlich; Jessica Gan; Peter St George-Hyslop; Satrajit S Ghosh; Enrico Glaab; Robert C Green; Yuanfang Guan; Ming-Yi Hong; Chao Huang; Jinseub Hwang; Joseph Ibrahim; Paolo Inglese; Anandhi Iyappan; Qijia Jiang; Yuriko Katsumata; John S K Kauwe; Arno Klein; Dehan Kong; Roland Krause; Emilie Lalonde; Mario Lauria; Eunjee Lee; Xihui Lin; Zhandong Liu; Julie Livingstone; Benjamin A Logsdon; Simon Lovestone; Tsung-Wei Ma; Ashutosh Malhotra; Lara M Mangravite; Taylor J Maxwell; Emily Merrill; John Nagorski; Aishwarya Namasivayam; Manjari Narayan; Mufassra Naz; Stephen J Newhouse; Thea C Norman; Ramil N Nurtdinov; Yen-Jen Oyang; Yudi Pawitan; Shengwen Peng; Mette A Peters; Stephen R Piccolo; Paurush Praveen; Corrado Priami; Veronica Y Sabelnykova; Philipp Senger; Xia Shen; Andrew Simmons; Aristeidis Sotiras; Gustavo Stolovitzky; Sabina Tangaro; Andrea Tateo; Yi-An Tung; Nicholas J Tustison; Erdem Varol; George Vradenburg; Michael W Weiner; Guanghua Xiao; Lei Xie; Yang Xie; Jia Xu; Hojin Yang; Xiaowei Zhan; Yunyun Zhou; Fan Zhu; Hongtu Zhu; Shanfeng Zhu Journal: Alzheimers Dement Date: 2016-04-11 Impact factor: 21.566
Authors: Emma Lawrence; Carolin Vegvari; Alison Ower; Christoforos Hadjichrysanthou; Frank De Wolf; Roy M Anderson Journal: J Alzheimers Dis Date: 2017 Impact factor: 4.472
Authors: Ridho Rahmadi; Perry Groot; Marieke Hc van Rijn; Jan Ajg van den Brand; Marianne Heins; Hans Knoop; Tom Heskes Journal: Stat Methods Med Res Date: 2017-06-28 Impact factor: 3.021